Relmada Therapeutics (RLMD) Share-based Compensation (IS) (2024 - 2026)
Relmada Therapeutics (RLMD) reported Share-based Compensation (IS) of $956,200 for Q1 2026, down 73.2% from $3.57 million a year earlier and down 70.8% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Relmada Therapeutics' Share-based Compensation (IS) came in at $12.19 million, down 52.1% year-over-year; for FY2025, it came in at $14.81 million, down 50.9% from FY2024.
- By year, Share-based Compensation (IS) came in at $30.18 million in FY2024.
- The Q1 2026 figure ranks as the lowest quarterly Share-based Compensation (IS) in data going back to Q1 2024.
- Year over year, Share-based Compensation (IS) has now declined in each of the last five quarters, with an average decline of 55.1% over the last five quarters.
- Per Business Quant data, the three quarters before Q1 2026 came in at $3.28 million (Q4 2025), $3.61 million (Q3 2025) and $4.35 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Relmada Therapeutics | 404.28 Mn | 404.28 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 956,200.00 |
| Dec 31, 2025 | 3.28 Mn |
| Sep 30, 2025 | 3.61 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Mar 31, 2025 | 3.57 Mn |
| Dec 31, 2024 | 6.73 Mn |
| Sep 30, 2024 | 7.95 Mn |
| Jun 30, 2024 | 7.21 Mn |
| Mar 31, 2024 | 8.30 Mn |
API Access
Relmada Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();